KRAS and non-small cell lung carcinoma: In this study, we identified miR-16 as significantly downregulated in NSCLC compared to the adjacent noncancerous lung tissue counterpart, and we showed that the levels of miR-16 are significantly reduced in KRAS-mutated primary NSCLC compared to KRAS-nonmutated NSCLC.